T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients
CHOP Oncologists Update Analysis in Pivotal Global Trial of CAR T-Cell Treatment for Relapsed or Refractory ALL
Published on in CHOP News , Cancer Connections